Belite Bio, Inc. (BLTE)
177.46
-5.70
(-3.11%)
USD |
NASDAQ |
Sep 10, 12:51
Belite Bio Shareholders Equity (Quarterly) : 776.64M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 776.64M |
| March 31, 2026 | 795.79M |
| December 31, 2025 | 770.49M |
| September 30, 2025 | 274.08M |
| June 30, 2025 | 149.88M |
| March 31, 2025 | 158.07M |
| December 31, 2024 | 145.82M |
| Date | Value |
|---|---|
| September 30, 2024 | 112.20M |
| June 30, 2024 | 114.59M |
| March 31, 2024 | 96.47M |
| December 31, 2023 | 90.43M |
| September 30, 2023 | 52.79M |
| June 30, 2023 | 55.72M |
| March 31, 2023 | 35.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 63.61M |
| CorMedix, Inc. | 460.83M |
| Eloxx Pharmaceuticals, Inc. | 46.42M |
| Cannabis Global, Inc. | -4.772M |
| Breakthrough Chemistry, Inc. | 0.8373M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 791.58M |
| Total Liabilities (Quarterly) | 14.95M |